Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6869939 | BAXTER HLTHCARE | Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
May, 2022
(9 months ago) | |
US7635773 | BAXTER HLTHCARE | Sulfoalkyl ether cyclodextrin compositions |
Mar, 2029
(6 years from now) |
Market Authorisation Date: 24 December, 2008
Treatment: NA
Dosage: INJECTABLE;INJECTION
11
United States
7
Japan
4
European Union
3
Israel
3
Mexico
3
China
3
Canada
2
Korea, Republic of
2
Australia
2
Spain
2
Slovenia
2
Denmark
1
Austria
1
Hong Kong
1
Brazil
1
Cyprus
1
Hungary
1
Portugal
1
EA
1
New Zealand
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic